Effect of laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1c levels in diabetic patients: a matched-cohort analysis

Surgery for Obesity and Related Diseases

Volumn 5, Issue 1, 2009, Pages 4-10

  Mumme, Daniel E ^a   Mathiason, Michelle A ^a   Kallies, Kara J ^a   Kothari, Shanu N ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

Bariatric surgery; Diabetes mellitus; Hemoglobin A1c; Laparoscopic Roux en Y gastric bypass; Obesity

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC OBESITY; DIABETIC PATIENT; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SEX RATIO; STOMACH BYPASS;

CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 58249086541     PISSN: 15507289     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soard.2008.11.009     Document Type: Article

References (28)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
3. Saaddine J.B., Engelgau M.M., Beckles G.L., Gregg E.W., Thompson T.J., and Narayan K.M. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136 (2002) 565-574
4. National Institutes of Health. The National Institutes of Health (NIH) Consensus Development Program: gastrointestinal surgery for severe obesity. http://consensus.nih.gov/1991/1991GISurgeryObesity084html.htm Accessed August 20, 2008
5. Kothari S.N., Boyd W.C., Larson C.A., Gustafson H.L., Lambert P.J., and Mathiason M.A. Training of a minimally invasive bariatric surgeon: are laparoscopic fellowships the answer?. Obes Surg 15 (2005) 323-329
6. Torquati A., Lutfi R., Abumrad N., and Richards W.O. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?. J Gastrointest Surg 9 (2005) 1112-1116
7. Kilpatrick E.S. Glycated haemoglobin in the year 2000. J Clin Pathol 53 (2000) 335-339
8. National Diabetes Information Clearinghouse. Complications of diabetes. http://diabetes.niddk.nih.gov/ Accessed August 20, 2008
9. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 141 (2004) 413-420
10. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
11. Ferchak C.V., and Meneghini L.F. Obesity, bariatric surgery and type 2 diabetes-a systematic review. Diabetes Metab Res Rev 20 (2004) 438-445
12. Alexandrides T.K., Skroubis G., and Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 17 (2007) 176-184
13. Parikh M., Ayoung-Chee P., Romanos E., et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205 (2007) 631-635
14. Kim T.H., Daud A., Ude A.O., et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 20 (2006) 202-209
15. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
16. Dixon J.B., O'Brien P.E., Playfair J., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299 (2008) 316-323
17. Cummings D.E., Overduin J., and Foster-Schubert K.E. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89 (2004) 2608-2615
18. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it?. An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-350
19. Cummings S., Apovian C.M., and Khaodhiar L. Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108 (2008) S40-S44
20. Broglio F., Arvat E., Benso A., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
21. Rubino F., Forgione A., Cummings D.E., et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244 (2006) 741-749
22. MacDonald Jr. K.G., Long S.D., Swanson M.S., et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
23. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
24. Sugerman H.J., Wolfe L.G., Sica D.A., and Clore J.N. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237 (2003) 751-756
25. Dixon J.B., and O'Brien P.E. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25 (2002) 358-363
26. The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 30 (2007) 1374-1383
27. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
28. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572